Overview

Dose-Dependent Effects of Intraoperative Tranexamic Acid on Surgical Bleeding and Transfusion Requirements in Multilevel Thoracolumbar Spinal Surgery

Status:
COMPLETED

Trial end date:
2024-04-01

Target enrollment:

Participant gender:

Summary

Multilevel spinal stabilization surgery is frequently associated with substantial blood loss and increased transfusion requirements. Tranexamic acid (TXA), an antifibrinolytic agent, reduces perioperative bleeding, but the optimal intravenous dosing regimen remains controversial. This study aimed to compare the efficacy and safety of two TXA dosing protocols in patients undergoing 3-level spinal stabilization surgery.

Phase:

Details

Lead Sponsor:

Dr. Lutfi Kirdar Kartal Training and Research Hospital